$60.5 Million is the total value of CVI Holdings, LLC's 47 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 5.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TIMKENSTEEL CORPnote 6.000% 6/0 | $14,860,000 | -7.6% | 10,455,000 | 0.0% | 24.58% | +22.7% | ||
ANI PHARMACEUTICALS INCnote 3.000%12/0 | $9,530,000 | -6.1% | 9,000,000 | 0.0% | 15.76% | +24.8% | ||
SENSEONICS HLDGS INCnote 5.250% 2/0 | $2,435,000 | +14.3% | 1,500,000 | 0.0% | 4.03% | +51.9% | ||
TPIV | TAPIMMUNE INC | $2,263,000 | -4.0% | 250,000 | 0.0% | 3.74% | +27.5% | |
CHEKZ | CHECK CAP LTD*w exp 05/03/202 | $102,000 | +9.7% | 136,364 | 0.0% | 0.17% | +45.7% | |
SHIPW | SEANERGY MARITIME HLDGS CORP*w exp 11/10/202 | $100,000 | +3.1% | 1,180,400 | 0.0% | 0.16% | +36.4% | |
BVXVW | BIONDVAX PHARMACEUTICALS LTD*w exp 05/15/202 | $85,000 | -7.6% | 72,800 | 0.0% | 0.14% | +22.6% | |
SGLBW | SIGMA LABS INC*w exp 02/15/202 | $66,000 | -12.0% | 214,500 | 0.0% | 0.11% | +17.2% | |
AMRHW | AMERI HLDGS INC*w exp 11/08/202 | $23,000 | +9.5% | 125,503 | 0.0% | 0.04% | +46.2% | |
APOPW | CELLECT BIOTECHNOLOGY LTD*w exp 08/03/202 | $23,000 | -8.0% | 12,570 | 0.0% | 0.04% | +22.6% | |
SNGXW | SOLIGENIX INC*w exp 11/14/202 | $21,000 | +23.5% | 61,000 | 0.0% | 0.04% | +66.7% | |
APDNW | APPLIED DNA SCIENCES INC*w exp 11/21/201 | $7,000 | -22.2% | 31,407 | 0.0% | 0.01% | +9.1% | |
BNTCW | BENITEC BIOPHARMA LTD*w exp 08/14/202 | $6,000 | 0.0% | 50,000 | 0.0% | 0.01% | +42.9% | |
MYNDW | MYND ANALYTICS INC*w exp 06/29/202 | $3,000 | 0.0% | 13,700 | 0.0% | 0.01% | +25.0% | |
CYTXZ | CYTORI THERAPEUTICS INC*w exp 05/28/202 | $1,000 | -87.5% | 259,200 | 0.0% | 0.00% | -80.0% | |
UUUUWS | ENERGY FUELS INC*w exp 09/20/202 | $0 | – | 277,777 | 0.0% | 0.00% | – | |
EYEGW | EYEGATE PHARMACEUTICALS INC*w exp 08/05/202 | $0 | -100.0% | 12,900 | 0.0% | 0.00% | -100.0% | |
NSPRZ | INSPIREMD INC*w exp 03/14/202 | $0 | -100.0% | 48,000 | 0.0% | 0.00% | -100.0% | |
ADXSW | ADVAXIS INC*w exp 10/22/201 | $0 | -100.0% | 15,150 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SENSEONICS HLDGS INC | 20 | Q4 2022 | 5.2% |
VERB TECHNOLOGY CO INC | 20 | Q1 2024 | 0.2% |
CHECK CAP LTD | 20 | Q1 2023 | 0.2% |
MEDIGUS LTD | 19 | Q2 2023 | 0.1% |
VERIFYME INC | 17 | Q2 2024 | 0.0% |
GEOVAX LABS INC | 16 | Q2 2024 | 0.0% |
BREEZE HOLDINGS ACQUISITN CO | 14 | Q1 2024 | 0.1% |
LEXARIA BIOSCIENCE CORP | 14 | Q2 2024 | 0.1% |
AMPLITECH GROUP INC | 14 | Q2 2024 | 0.0% |
VERSUS SYSTEMS INC | 14 | Q2 2024 | 0.0% |
View CVI Holdings, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-15 |
13F-HR | 2024-05-07 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-16 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View CVI Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.